Kilitch Drugs (India) consolidated net profit rises 104.81% in the December 2024 quarter
Net profit of Kilitch Drugs (India) rose 104.81% to Rs 5.96 crore in the quarter ended December 2024 as against Rs 2.91 crore during the previous quarter ended December 2023. Sales rose 76.69% to Rs 56.17 crore in the quarter ended December 2024 as against Rs 31.79 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 56.17 | 31.79 | 77 |
| OPM % | 15.54 | 7.17 | - |
| PBDT | 9.06 | 3.64 | 149 |
| PBT | 8.25 | 2.82 | 193 |
| NP | 5.96 | 2.91 | 105 |
